Omron Corp. (OTCMKTS:OMRNY) Short Interest Update

Omron Corp. (OTCMKTS:OMRNY) was the target of a significant drop in short interest in the month of April. As of April 15th, there was short interest totaling 9,765 shares, a drop of 52.7% from the March 31st total of 20,636 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily volume of 296,738 shares, the days-to-cover ratio is currently 0.0 days.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Omron stock. GAMMA Investing LLC grew its holdings in shares of Omron Corp. (OTCMKTS:OMRNY) by 50.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,129 shares of the company’s stock after buying an additional 716 shares during the quarter. GAMMA Investing LLC’s holdings in Omron were worth $54,000 at the end of the most recent reporting period. 1.09% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded shares of Omron from a “strong sell” rating to a “hold” rating in a report on Monday, January 19th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the stock has an average rating of “Hold”.

Omron Stock Up 2.4%

Shares of OTCMKTS OMRNY opened at $32.88 on Tuesday. The stock has a market capitalization of $6.47 billion, a P/E ratio of 41.62, a P/E/G ratio of 0.37 and a beta of 1.00. The company has a 50-day moving average price of $30.48 and a 200-day moving average price of $27.90. Omron has a 1 year low of $23.23 and a 1 year high of $35.90. The company has a debt-to-equity ratio of 0.13, a current ratio of 2.11 and a quick ratio of 1.37.

Omron (OTCMKTS:OMRNY) last issued its quarterly earnings data on Thursday, February 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.36 by ($0.19). The business had revenue of $1.41 billion for the quarter, compared to analyst estimates of $1.38 billion. Omron had a net margin of 2.80% and a return on equity of 2.46%. Omron has set its FY 2025 guidance at 0.960-0.960 EPS. On average, equities research analysts forecast that Omron will post 1.22 EPS for the current fiscal year.

Omron Company Profile

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.